NCT04029181View on ClinicalTrials.gov

ImmunoPET With an Anti-CD8 Imaging Agent

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 14, 2019

Primary Completion Date

December 28, 2022

Study Completion Date

December 31, 2024

Conditions
Metastatic CancerUnresectable Malignant Neoplasm
Interventions
OTHER

Anti-CD8 PET imaging agent

An imaging agent radiolabelled with 89Zr developed for in human PET imaging of CD8

Trial Locations (1)

Unknown

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER